Combining scientific and clinical rigor with the tech and entertainment industries, Akili is challenging the status quo of medicine. Akili is pioneering the development of digital treatments and care solutions to help people affected by cognitive impairments, including those living with ADHD, depression, autism and multiple sclerosis. Akili’s treatments directly activate the networks in the brain responsible for cognitive function and have been rigorously testing in extensive clinical studies, including prospective randomized, controlled trials. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s treatments are delivered through captivating action video game experiences.